Dr. David Kopecky supports our life sciences patent prosecution and litigation practices in the areas of chemistry and biotechnology. He has extensive research experience in organic chemistry and medicinal chemistry.
David received his Ph.D. in Organic Chemistry in 2001 from the University of California, Irvine. As a graduate student, he completed a formal total synthesis of leucascandrolide A, a marine macrolide with anticancer and antifungal activities. He also developed the Mukaiyama Aldol-Prins cyclization cascade reaction, and examined asymmetric alkylation reactions of pseudoephedrine amides.
Before joining the firm, David worked as a medicinal chemist at Amgen from 2001 to 2017 where he contributed to six major small molecule drug discovery programs spanning a variety of disease indications including oncology, cardiovascular diseases, and metabolic disorders. His work at Amgen focused upon the rational design of drug candidate molecules by evaluating structure activity relationships and pharmacokinetics and drug metabolism properties.
David has been an author on 16 organic chemistry and medicinal chemistry publications, and has been an inventor on 27 Amgen small molecule patents.
Credentials
Education
- Ph.D., Chemistry, University of California, Irvine, 2001
- M.S., Chemistry, California Institute of Technology, 1998
- B.Sc., Chemistry, Brown University, 1994
Admissions
- *Not admitted to the practice of law
- U.S. Patent and Trademark Office